Our pharmaceutical-grade Lumefantrine, better known as benflumetol, is an integral component utilized in anti-malarial drugs manufacturing. Ensuring optimal compliance with top-tier industry and regulatory safeguards, the high-purity Lumefantrine API– offered in a powdery form– bolsters superior medicinal efficacy while conforming to a certified Drug Master File (DMF).
Strictly adhering to industry-leading practices, Lumefantrine comes in a consistent powdery form, boasting a chemical formula of C30H32Cl3NO and a molecular weight of 528.9 g/mol. This active pharmaceutical ingredient (API) guarantees functionality and reliability.
Despite low solubility in water, Lumefantrine readily dissolves in organic solvents. It necessitates mindful handling as skin contact or inhalation could trigger irritation. Avoid contact with eyes and inadvertent ingestion for safety.
Lumefantrine’s antimalarial prominence stems from its interaction with heme–a toxic by-product of hemoglobin destruction–thus elucidating its mechanism of action. Frequently paired with Artemether, Lumefantrine serves as a preferred remedy for combating malaria; particularly that triggered by Plasmodium falciparum infections. It continues to demonstrate effectiveness in regions witnessing chloroquine resistance.
The Lumefantrine API stands apart with its pharmaceutical-grade conformity, guaranteeing stability and trustworthiness. Its application in anti-malarial drug productions accentuates enhanced health results in malaria-prevalent zones. Trust our Lumefantrine API in pharmaceutical explorations and make a marked impact.